TTR and polyneuropathy: Beyond kinases, a small library of SF inhibitors of transthyretin (TTR) was developed to react covalently with the pKa-perturbed Lys15 in the thyroxine binding site.56 These inhibitors kinetically stabilized TTR thus preventing fibrillation (a cause of polyneuropathy).